Showing results (1-10 of 4,660) with videos related to
Sort By:
Pageof 466
Pathology, Research and Practice|July 1, 1996
Molecular mechanisms of multidrug resistance in cancer chemotherapyK Nooter, G StoterNederlands Tijdschrift Voor Geneeskunde|July 13, 2001
[Treatment of metastatic testicular carcinoma according to prognosis; new development]R de Wit, G StoterLeukemia & Lymphoma|February 1, 1996
Multidrug resistance-associated protein (MRP) in haematological malignanciesK Nooter, H Burger, G StoterEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancerA S Planting, G Stoter, J VerweijCancer Treatment Reviews|September 28, 2000
Farnesyl transferase inhibitors: current developments and future perspectivesF A Eskens, G Stoter, J VerweijCancer Treatment Reviews|September 1, 1995
Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effectsL C Pronk, G Stoter, J VerweijCancer|January 1, 1993
Stenting in malignant vena caval obstructionM Oudkerk, F M Heystraten, G StoterAnnals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Interferon-alpha induced Raynaud's syndromeW H Kruit, A M Eggermont, G StoterCancer Immunology, Immunotherapy : CII|September 4, 1999
The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cellsW H Kruit, P I Schmitz, G StoterAmerican Journal of Clinical Oncology|April 1, 1993
Piritrexim-induced pulmonary toxicityR de Wit, J Verweij, R Slingerland, et al.Pageof 466